Literature DB >> 20978914

Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking.

Ping Lan1, Wan-Na Chen, Zhi-Jian Huang, Ping-Hua Sun, Wei-Min Chen.   

Abstract

Novel anti-HIV-1 agents derived from betulinic acid have been greatly concerned. 3D-QSAR and molecular docking studies were applied to rationalize the structural requirements responsible for the anti-HIV activity of these compounds. The CoMFA and CoMSIA models resulted from 28 molecules gave r(cv)² values of 0.599 and 0.630, r² values of 0.994 and 0.958, respectively. To estimate the predictive ability of the 3D-QSAR model, an external validation was employed. Based on the contour maps generated from both CoMFA and CoMSIA, we have identified some key features in the betulinic acid derivatives that are responsible for the anti-HIV activity. Molecular docking was used to explore the binding mode between these derivatives and HIV gp120. We have therefore designed a series of novel betulinic acid derivatives by utilizing the SAR results revealed in the present study, which were predicted with excellent potencies in the developed models. The results provide a valuable method to design new betulinic acid derivatives as anti-HIV-1 agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978914     DOI: 10.1007/s00894-010-0870-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  22 in total

1.  CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.

Authors:  Peng Lu; Xia Wei; Ruisheng Zhang
Journal:  Eur J Med Chem       Date:  2010-05-21       Impact factor: 6.514

2.  Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.

Authors:  Kunal Roy; Partha Pratim Roy
Journal:  Eur J Med Chem       Date:  2008-12-16       Impact factor: 6.514

3.  CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents.

Authors:  Vanangamudi Murugesan; Yenamandra S Prabhakar; Seturam B Katti
Journal:  J Mol Graph Model       Date:  2008-11-21       Impact factor: 2.518

4.  Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action.

Authors:  M Evers; C Poujade; F Soler; Y Ribeill; C James; Y Lelièvre; J C Gueguen; D Reisdorf; I Morize; R Pauwels; E De Clercq; Y Hénin; A Bousseau; J F Mayaux; J B Le Pecq; N Dereu
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

5.  3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors.

Authors:  Ping Lan; Zhi-Jian Huang; Jun-Rong Sun; Wei-Min Chen
Journal:  Int J Mol Sci       Date:  2010-09-17       Impact factor: 5.923

6.  Anti-AIDS agents. 78. Design, synthesis, metabolic stability assessment, and antiviral evaluation of novel betulinic acid derivatives as potent anti-human immunodeficiency virus (HIV) agents.

Authors:  Keduo Qian; Donglei Yu; Chin-Ho Chen; Li Huang; Susan L Morris-Natschke; Theodore J Nitz; Karl Salzwedel; Mary Reddick; Graham P Allaway; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

7.  Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents.

Authors:  I C Sun; H K Wang; Y Kashiwada; J K Shen; L M Cosentino; C H Chen; L M Yang; K H Lee
Journal:  J Med Chem       Date:  1998-11-05       Impact factor: 7.446

8.  CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists.

Authors:  Elena Cichero; Sara Cesarini; Luisa Mosti; Paola Fossa
Journal:  J Mol Model       Date:  2009-10-01       Impact factor: 1.810

9.  Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors.

Authors:  Zhao Dang; Weihong Lai; Keduo Qian; Phong Ho; Kuo-Hsiung Lee; Chin-Ho Chen; Li Huang
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

10.  Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.

Authors:  Arijit Basu; Kalsariya Jasu; Venkatesan Jayaprakash; Nibha Mishra; P Ojha; S Bhattacharya
Journal:  Eur J Med Chem       Date:  2008-10-10       Impact factor: 6.514

View more
  2 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944

2.  Predictive classification models and targets identification for betulin derivatives as Leishmania donovani inhibitors.

Authors:  Yuezhou Zhang; Henri Xhaard; Leo Ghemtio
Journal:  J Cheminform       Date:  2018-08-17       Impact factor: 5.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.